{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:39:22Z","timestamp":1786991962947,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CCSG P30 CA047904"],"award-info":[{"award-number":["CCSG P30 CA047904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI 136779"],"award-info":[{"award-number":["U01 AI 136779"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007408","name":"Medical Center, University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015166","name":"UPMC Enterprises","doi-asserted-by":"publisher","award":["88906"],"award-info":[{"award-number":["88906"]}],"id":[{"id":"10.13039\/100015166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jcyt.2022.11.005","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:51:14Z","timestamp":1673484674000},"page":"432-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Manufacturing and validation of Good Manufacturing Practice\u2013compliant regulatory dendritic cells for infusion into organ transplant recipients"],"prefix":"10.1016","volume":"25","author":[{"given":"Alan F.","family":"Zahorchak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misty L.","family":"DeRiggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Muzzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Humar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9937-2637","authenticated-orcid":false,"given":"Fadi G.","family":"Lakkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9239-4980","authenticated-orcid":false,"given":"Yen-Michael S.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus W.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcyt.2022.11.005_bib0001","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MOT.0b013e328363319d","article-title":"Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients","volume":"18","author":"Geissler","year":"2013","journal-title":"Current opinion in organ transplantation"},{"issue":"4","key":"10.1016\/j.jcyt.2022.11.005_bib0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2016.7","article-title":"Mesenchymal stromal cells in renal transplantation: opportunities and challenges","volume":"12","author":"Casiraghi","year":"2016","journal-title":"Nature reviews nephrology"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0003","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Frontiers in immunology"},{"issue":"3","key":"10.1016\/j.jcyt.2022.11.005_bib0004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.trre.2019.05.001","article-title":"Regulatory dendritic cells for human organ transplantation","volume":"33","author":"Thomson","year":"2019","journal-title":"Transplantation reviews"},{"issue":"16","key":"10.1016\/j.jcyt.2022.11.005_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168415","article-title":"Tolerogenic dendritic cell-based approaches in autoimmunity","volume":"22","author":"Passeri","year":"2021","journal-title":"International journal of molecular sciences"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0006","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12896-015-0190-4","article-title":"Challenges in the translation and commercialization of cell therapies","volume":"15","author":"Dodson","year":"2015","journal-title":"BMC biotechnology"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0007","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0008","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2249.1996.d01-779.x","article-title":"Dendritic cells and tolerance induction","volume":"105","author":"Steptoe","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0009","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.jcyt.2022.11.005_bib0010","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0011","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-12-380995-7.00004-5","article-title":"How tolerogenic dendritic cells induce regulatory T cells","volume":"108","author":"Maldonado","year":"2010","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2003.tb06029.x","article-title":"Dendritic cell function in vivo during the steady state: a role in peripheral tolerance","volume":"987","author":"Steinman","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"10.1016\/j.jcyt.2022.11.005_bib0013","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.20082394","article-title":"Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity","volume":"206","author":"Ohnmacht","year":"2009","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.jcyt.2022.11.005_bib0014","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/eji.201343862","article-title":"Regulation of the tolerogenic function of steady-state DCs","volume":"44","author":"Probst","year":"2014","journal-title":"European journal of immunology"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-6143.2002.20403.x","article-title":"Dendritic cells, tolerance induction and transplant outcome","volume":"2","author":"Coates","year":"2002","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.jcyt.2022.11.005_bib0016","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.jcyt.2022.11.005_bib0017","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.smim.2011.06.007","article-title":"Tolerogenic dendritic cells and their role in transplantation","volume":"23","author":"Ezzelarab","year":"2011","journal-title":"Seminars in immunology"},{"issue":"5","key":"10.1016\/j.jcyt.2022.11.005_bib0018","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ajt.12229","article-title":"Plasmacytoid dendritic cells: no longer an enigma and now key to transplant tolerance?","volume":"13","author":"Rogers","year":"2013","journal-title":"Am J Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.jcyt.2022.11.005_bib0019","article-title":"Tolerogenic dendritic cells for autoimmune disease and transplantation","volume":"67","author":"Thomson","year":"2008","journal-title":"Annals of the rheumatic diseases"},{"issue":"2","key":"10.1016\/j.jcyt.2022.11.005_bib0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/08830180903281193","article-title":"Development of dendritic cell-based immunotherapy for autoimmunity","volume":"29","author":"Hilkens","year":"2010","journal-title":"Int Rev Immunol"},{"issue":"9","key":"10.1016\/j.jcyt.2022.11.005_bib0021","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1136\/ard.2011.151654","article-title":"Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?","volume":"70","author":"Stoop","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"issue":"2","key":"10.1016\/j.jcyt.2022.11.005_bib0022","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autrev.2013.09.008","article-title":"Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?","volume":"13","author":"Van Brussel","year":"2014","journal-title":"Autoimmunity reviews"},{"issue":"1 Suppl","key":"10.1016\/j.jcyt.2022.11.005_bib0023","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00007890-200201151-00008","article-title":"Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease","volume":"73","author":"Lu","year":"2002","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.jcyt.2022.11.005_bib0024","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8","article-title":"Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo","volume":"30","author":"Lutz","year":"2000","journal-title":"European journal of immunology"},{"issue":"5","key":"10.1016\/j.jcyt.2022.11.005_bib0025","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.169.5.2390","article-title":"Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions","volume":"169","author":"Eto","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5730674","article-title":"Effects of adoptive transfer of tolerogenic dendritic cells on allograft survival in organ transplantation models: an overview of systematic reviews","volume":"2016","author":"Zhou","year":"2016","journal-title":"Journal of immunology research"},{"issue":"8","key":"10.1016\/j.jcyt.2022.11.005_bib0027","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.TP.0000158277.50073.35","article-title":"Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression","volume":"79","author":"Beriou","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0028","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fimmu.2018.00274","article-title":"Tolerogenic dendritic cells in solid organ transplantation: where do we stand?","volume":"9","author":"Marin","year":"2018","journal-title":"Frontiers in immunology"},{"issue":"9","key":"10.1016\/j.jcyt.2022.11.005_bib0029","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.4049\/jimmunol.177.9.5868","article-title":"Alternatively activated\" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig","volume":"177","author":"Lan","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2022.11.005_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/TP.0b013e31815e870e","article-title":"Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression","volume":"85","author":"Ikeguchi","year":"2008","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.jcyt.2022.11.005_bib0031","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","article-title":"Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance","volume":"178","author":"Turnquist","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2022.11.005_bib0032","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/ajt.12708","article-title":"Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation","volume":"14","author":"Segovia","year":"2014","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2022.11.005_bib0033","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.tp.0000268582.21168.f6","article-title":"Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques","volume":"84","author":"Zahorchak","year":"2007","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.jcyt.2022.11.005_bib0034","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/ajt.12310","article-title":"Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates","volume":"13","author":"Ezzelarab","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2022.11.005_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri1256","article-title":"Dendritic cells: emerging pharmacological targets of immunosuppressive drugs","volume":"4","author":"Hackstein","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2022.11.005_bib0036","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.193.2.233","article-title":"Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells","volume":"193","author":"Dhodapkar","year":"2001","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jcyt.2022.11.005_bib0037","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V100.1.174","article-title":"Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans","volume":"100","author":"Dhodapkar","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jcyt.2022.11.005_bib0038","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1136\/ard.2009.126383","article-title":"Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis","volume":"69","author":"Harry","year":"2010","journal-title":"Annals of the rheumatic diseases"},{"issue":"1","key":"10.1016\/j.jcyt.2022.11.005_bib0039","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1479-5876-9-89","article-title":"Comparative study of clinical grade human tolerogenic dendritic cells","volume":"9","author":"Naranjo-Gomez","year":"2011","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.jcyt.2022.11.005_bib0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2011.11.011","article-title":"IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction\u2013a comparative study of human clinical-applicable DC","volume":"142","author":"Boks","year":"2012","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2022.11.005_bib0041","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.vaccine.2011.10.081","article-title":"Differential effects of monophosphoryl lipid A and cytokine cocktail as maturation stimuli of immunogenic and tolerogenic dendritic cells for immunotherapy","volume":"30","author":"Raich-Regue","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jcyt.2022.11.005_bib0042","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcyt.2022.11.005_bib0043","first-page":"169","article-title":"Safety and preliminary evidence of efficacy in a phase I clinical trial of autologous tolerizing dendritic cells exposed to citrullinated peptides (Rheumavax) in patients with rheumatoid arthritis","volume":"70","author":"Thomas","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"issue":"290","key":"10.1016\/j.jcyt.2022.11.005_bib0044","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Science translational medicine"},{"issue":"12","key":"10.1016\/j.jcyt.2022.11.005_bib0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ecco-jcc\/jjv144","article-title":"Intraperitoneal administration of autologous tolerogenic dendritic cells for refractory crohn's disease: a phase I study","volume":"9","author":"Jauregui-Amezaga","year":"2015","journal-title":"Journal of Crohn's & colitis"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0046","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"8463","article-title":"Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial","volume":"116","author":"Zubizarreta","year":"2019"},{"issue":"10237","key":"10.1016\/j.jcyt.2022.11.005_bib0047","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0048","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40425-016-0128-y","article-title":"Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer","volume":"4","author":"Radomski","year":"2016","journal-title":"Journal for immunotherapy of cancer"},{"issue":"7","key":"10.1016\/j.jcyt.2022.11.005_bib0049","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcyt.2020.03.432","article-title":"What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings","volume":"22","author":"Ten Ham","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellimm.2017.08.008","article-title":"High PD-L1\/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation","volume":"323","author":"Zahorchak","year":"2018","journal-title":"Cellular immunology"},{"issue":"2","key":"10.1016\/j.jcyt.2022.11.005_bib0051","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/tri.13504","article-title":"Tolerogenic dendritic cells in organ transplantation,","volume":"33","author":"Ochando","year":"2020","journal-title":"Transplant international"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0052","doi-asserted-by":"crossref","first-page":"e2300","DOI":"10.7717\/peerj.2300","article-title":"Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies","volume":"4","author":"Lord","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0053","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3389\/fimmu.2018.02062","article-title":"Searching for the transcriptomic signature of immune tolerance induction-biomarkers of safety and functionality for tolerogenic dendritic cells and regulatory macrophages","volume":"9","author":"Navarro-Barriuso","year":"2018","journal-title":"Frontiers in immunology"},{"issue":"6","key":"10.1016\/j.jcyt.2022.11.005_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.11.011","article-title":"Human tolerogenic dendritic cells regulate immune responses through lactate synthesis","volume":"30","author":"Marin","year":"2019","journal-title":"Cell metabolism"},{"issue":"4","key":"10.1016\/j.jcyt.2022.11.005_bib0055","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/TP.0000000000003315","article-title":"Preclinical assessment of autologous tolerogenic dendritic cells from end-stage renal disease patients","volume":"105","author":"Bouchet-Delbos","year":"2021","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jcyt.2022.11.005_bib0056","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Annals of the rheumatic diseases"},{"issue":"5","key":"10.1016\/j.jcyt.2022.11.005_bib0057","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.4049\/jimmunol.1100762","article-title":"Cutting Edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients","volume":"187","author":"Hutchinson","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2022.11.005_bib0058","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1038\/s41467-018-05167-8","article-title":"TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity","volume":"9","author":"Riquelme","year":"2018","journal-title":"Nature communications"},{"issue":"1-2","key":"10.1016\/j.jcyt.2022.11.005_bib0059","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jim.2011.08.010","article-title":"Cryopreservation of monocytes or differentiated immature DCs leads to an altered cytokine response to TLR agonists and microbial stimulation","volume":"373","author":"Meijerink","year":"2011","journal-title":"Journal of immunological methods"},{"key":"10.1016\/j.jcyt.2022.11.005_bib0060","doi-asserted-by":"crossref","first-page":"39071","DOI":"10.1038\/srep39071","article-title":"Mature dendritic cell derived from cryopreserved immature dendritic cell shows impaired homing ability and reduced anti-viral therapeutic effects","volume":"6","author":"Zhou","year":"2016","journal-title":"Scientific reports"},{"issue":"2","key":"10.1016\/j.jcyt.2022.11.005_bib0061","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/trf.15028","article-title":"Freezing of dendritic cells with trehalose as an additive in the conventional freezing medium results in improved recovery after cryopreservation","volume":"59","author":"Shinde","year":"2019","journal-title":"Transfusion"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492201026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492201026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:48:33Z","timestamp":1761443313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532492201026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S146532492201026X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.11.005","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manufacturing and validation of Good Manufacturing Practice\u2013compliant regulatory dendritic cells for infusion into organ transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}